Start your recurring gift this holiday season. Donate today!

neuropathy news image

Neuropathy News Nov. 2025

Image with the text: CRTS Updates.

Research update with Dr. Michelassi

Francesco Michelassi, MD, PhD, Physician and Lead Scientist at the University of Virginia Health and the 2024 Clinical Research Training Scholarship (CRTS) recipient, shares his work studying Chemotherapy-Induced Peripheral Neuropathy (CIPN). He explains how his research could help protect nerves and lead to new treatments. 

Learn how FPN helped Dr. Michelassi start his independent research career. Watch the video. 

New members join the FPN Board

We’re pleased to welcome new board members, Jennie Starr and George Montague to the organization. Starr and Montague bring a diverse set of skills to the board and will be a great addition to our team.  

Learn more about Starr and Montague, and what they bring to the table. 

Celebrating FPN Day

On October 15, we celebrated our 18th anniversary – FPN Day. It was a moment to reflect on the progress we’ve made. It gave us the opportunity to thank the people who make our work possible—you, our supporters, researchers and patients.  

We surpassed our one-day fundraising goal of $18,000. Thank you for making this possible! 

Read more about FPN Day’s success. 

At-home research study for chemo-induced PN

Mayo Clinic is looking for adults who have moderate to severe chemotherapy-induced peripheral neuropathy to join a research study. The goal of the study is to see if a simple massage technique, done by a family caregiver, can help people with this type of nerve pain. 

Learn more about the study.

How scientists finally learned that nerves regrow

For decades, experts thought damaged nerves could never heal. New research shows that nerves can regrow, under the right conditions. This changes how we look at recovery after injury. 

This Scientific American article traces the groundbreaking discoveries that changed neuroscience forever. 

Chemo-induced neuropathy research on the rise

Chemotherapy induced peripheral neuropathy (CIPN) can impact up to 70% of chemo patients. The effects can linger long after chemotherapy has ended. Patients can be left with issues in their hands or feet ranging from pain and tingling to muscle weakness.  

Learn more about some of the research happening around CIPN. 

Our latest print newsletter

Donors get our printed newsletter in the mail twice a year. Check out the latest issue. Consider making a gift so you can get our next edition mailed to your doorstep! 

Help improve the lives of those with PN. Your contribution helps us support research and provide an improved quality of life for those affected.